id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
APHIS-2014-0063-0008,APHIS,APHIS-2014-0063,Final Regulatory Flexibility Analysis: VSTA Records and Reports Specific to Standards for Pharmacovigilance,Supporting & Related Material,Economic Analysis,2018-05-17T04:00:00Z,2018,5,,,2018-05-17T14:57:21Z,,0,0,090000648325508e
APHIS-2014-0063-0007,APHIS,APHIS-2014-0063,Virus-Serum-Toxin Act Records and Reports Specific to International Standards for Pharmacovigilance,Rule,Final Rule,2018-05-17T04:00:00Z,2018,5,2018-05-17T04:00:00Z,,2018-05-17T14:48:12Z,2018-10540,0,0,0900006483275f8e
APHIS-2014-0063-0002,APHIS,APHIS-2014-0063,VSTA Records and Reports Specific to Standards for Pharmacovigilance,Supporting & Related Material,Economic Analysis,2015-09-04T04:00:00Z,2015,9,,,2015-09-04T13:25:00Z,,0,0,0900006481c3b54b
APHIS-2014-0063-0001,APHIS,APHIS-2014-0063,VSTA Records and Reports Specific to International Standards for Pharmacovigilance,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2015-09-04T04:00:00Z,2015,9,2015-09-04T04:00:00Z,2015-11-04T04:59:59Z,2015-11-04T02:30:55Z,2015-21997,0,0,0900006481c5754a